172 related articles for article (PubMed ID: 22890830)
1. Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.
Zhang W; Guo N; Yu C; Wang H; Zhang Y; Xia H; Yu J; Lu J
Tumour Biol; 2012 Dec; 33(6):2209-16. PubMed ID: 22890830
[TBL] [Abstract][Full Text] [Related]
2. [Differential expressions of MDR-1, RRM-1, EGFR and ERCC-1 in primary tumors and metastatic lymph nodes of NSCLC patients].
Guo N; Li S; Zhang W; Yu C; Wang H; Zhang Y; Yu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Aug; 29(8):870-3. PubMed ID: 23948418
[TBL] [Abstract][Full Text] [Related]
3. Differences in the expression profiles of excision repair crosscomplementation group 1, x-ray repair crosscomplementation group 1, and betaIII-tubulin between primary non-small cell lung cancer and metastatic lymph nodes and the significance in mid-term survival.
Kang CH; Jang BG; Kim DW; Chung DH; Kim YT; Jheon S; Sung SW; Kim JH
J Thorac Oncol; 2009 Nov; 4(11):1307-12. PubMed ID: 19745766
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of annexin II expression in non-small cell lung cancer.
Luo CH; Liu QQ; Zhang PF; Li MY; Chen ZC; Liu YF
Clin Transl Oncol; 2013 Nov; 15(11):938-46. PubMed ID: 23529818
[TBL] [Abstract][Full Text] [Related]
5. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
Zhang Y; Ma M; Han B
Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sites.
Gomez-Roca C; Raynaud CM; Penault-Llorca F; Mercier O; Commo F; Morat L; Sabatier L; Dartevelle P; Taranchon E; Besse B; Validire P; Italiano A; Soria JC
J Thorac Oncol; 2009 Oct; 4(10):1212-20. PubMed ID: 19687761
[TBL] [Abstract][Full Text] [Related]
8. ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.
Ni SS; Zhang J; Zhao WL; Dong XC; Wang JL
Tumour Biol; 2013 Jun; 34(3):1813-8. PubMed ID: 23475633
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study.
Li H; Zhou RJ; Zhang GQ; Xu JP
Tumour Biol; 2013 Jun; 34(3):1807-12. PubMed ID: 23471668
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer.
Lin G; Sun L; Wang R; Guo Y; Xie C
J Thorac Oncol; 2014 Feb; 9(2):170-8. PubMed ID: 24419413
[TBL] [Abstract][Full Text] [Related]
11. ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy.
Ozdemir O; Ozdemir P; Veral A; Uluer H; Ozhan MH
Asian Pac J Cancer Prev; 2013; 14(8):4679-83. PubMed ID: 24083725
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
Zhang H; Duan CJ; Chen W; Wang SQ; Zhang SK; Dong S; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2012; 13(5):2355-62. PubMed ID: 22901222
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1 protein expression in non-small cell lung cancers is correlated with prognosis.
Huang AL; Liu SG; Qi WJ; Zhao YF; Li YM; Lei B; Sheng WJ; Shen H
Asian Pac J Cancer Prev; 2014; 15(19):8143-7. PubMed ID: 25338997
[TBL] [Abstract][Full Text] [Related]
14. Expression of p114RhoGEF predicts lymph node metastasis and poor survival of squamous-cell lung carcinoma patients.
Song C; Gao Y; Tian Y; Han X; Chen Y; Tian DL
Tumour Biol; 2013 Jun; 34(3):1925-33. PubMed ID: 23512329
[TBL] [Abstract][Full Text] [Related]
15. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
16. Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy.
Xie KJ; He HE; Sun AJ; Liu XB; Sun LP; Dong XJ
Asian Pac J Cancer Prev; 2014; 15(6):2591-6. PubMed ID: 24761869
[TBL] [Abstract][Full Text] [Related]
17. Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.
Wang X; Du Z; Li L; Shi M; Yu Y
Int J Clin Exp Pathol; 2015; 8(9):10644-52. PubMed ID: 26617774
[TBL] [Abstract][Full Text] [Related]
18. Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke.
Liu X; Liu B; Cui Y; Wang F; Sun H; Lv F
Tumour Biol; 2014 Nov; 35(11):11677-83. PubMed ID: 25139095
[TBL] [Abstract][Full Text] [Related]
19. Expression of Molecular Markers in Primary Sites and Metastatic Lymph Nodes of Lung Cancer Patients.
Li J; Zhang W; Guo N; Yu J; Zhao Y; Li S
Med Sci Monit; 2017 Jan; 23():513-520. PubMed ID: 28130961
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta specifically enhances the metastatic attributes of murine lung adenocarcinoma: implications for human non-small cell lung cancer.
Vázquez PF; Carlini MJ; Daroqui MC; Colombo L; Dalurzo ML; Smith DE; Grasselli J; Pallotta MG; Ehrlich M; Bal de Kier Joffé ED; Puricelli L
Clin Exp Metastasis; 2013 Dec; 30(8):993-1007. PubMed ID: 23832740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]